- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07419022
Improv Music Therapy for Older Adults
February 20, 2026 updated by: University of California, San Francisco
Impact of Improvisation Music Therapy for Persons Living With Dementia and Their Care Partners
Older adults and their care partners will participate in music therapy sessions for approximately 8 weeks.
Before and after the 8 week study period, participants will fill out questionnaires about their mood, stress levels, and emotions.
During the music therapy sessions, they may be observed or asked questions about the music therapy sessions.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Karen C Barrett, PhD
- Phone Number: 4153534501
- Email: Karen.Barrett@ucsf.edu
Study Contact Backup
- Name: Howie Rosen, MD
- Phone Number: ]415 476-5567
- Email: howie.rosen@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94158
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria
Inclusion criteria for the Person Living with Dementia (PLWD) are:
- Age 60 and over, living independently in the community
- Medical diagnosis of Alzheimer's Disease
- Mild dementia defined as MoCA score between 16-20, or MMSE score between 19-24
- Sufficient visual and hearing acuity (age-related to normal hearing loss with assistive devices)
- English fluency rated fairly well to well (self-rated English fluency)
Inclusion Criteria for Caregiver are:
- Age 18 or Older
- Moderate to good English fluency (self-rated English fluency)
- Willing to participate in intervention with PLWD
Exclusion Criteria
Exclusion criteria for PLWD are:
- Medical diagnosis of severe dementia (any etiology)
- Non-AD dementia diagnosis (e.g., frontotemporal dementia)
- Serious medical condition (e.g., an end-stage disease requiring hospice, aphasia from stroke, paralysis, brain injury) requiring active medical management that would interfere with participation in the study
- Significant difficulty moving the hands or arms (severe arthritis, neuropathy)
- Plans to move out of the area within six months
Exclusion criteria for Caregiver are:
- Current but not prior severe psychiatric disorder (e.g., schizophrenia, bipolar disorder)
- Serious medical condition (e.g., an end-stage disease requiring hospice, aphasia from stroke, paralysis, brain injury) requiring active medical management that would interfere with participation in the study
- Plans to move out of the area
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Clinical Improvisation Immediately
|
Clinical improvisation music therapy offered as group sessions delivered by board-certified music therapist.
|
|
Experimental: Group B
Delayed Onset Clinical improvisation
|
Clinical improvisation music therapy offered as group sessions delivered by board-certified music therapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Science of Behavior Change (SOBC) Brief-COPE
Time Frame: Baseline and Post-Intervention, 8 weeks
|
The Brief COPE is a 28 item measure of strategies used for coping or regulating cognitions in response to stressors.
The questions assess the frequency with which a person uses different coping strategies (e.g.
"I've been turning to work or other activities to take my mind off strings") and the respondent gives a rating on a 5 item scale (1= I haven't been doing this at all to 4 I've been doing this a lot).
|
Baseline and Post-Intervention, 8 weeks
|
|
SOBC Perceived Stress Scale
Time Frame: Baseline and Post Intervention, 8 weeks
|
The Perceived Stress Scale ask participants about their feelings and thoughts during the last month.
There are 10 items and participants are asked how often they felt orr thought a certian way (0 = never to 4 very often)
|
Baseline and Post Intervention, 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dementia Mood Picture Test
Time Frame: Baseline and Post Intervention, 8 weeks
|
Participants are given large line face drawings with large font descriptors.
Participants are asked whether or not they are experiencing each mood ("Are you in a good mood?") and the intensity of the mood.
The test assesses the PLWD directly but focuses on six primary moods.
|
Baseline and Post Intervention, 8 weeks
|
|
SOBC Positive and Negative Affect (PANAS)
Time Frame: Baseline and Post Intervention, 8 weeks
|
The PANAS is a 20 item self-questionnaire.
Respondent is asked to read several words which describe different feelings and emotions.
Applicability of the emotion is scored by respondent on a 5 point Likert Scale (1 = very slightly or not at all to 5 = extremely).
Higher scores on Positive Affect items incidate greater intensity of positive emotions and higher scores on Negative Affect indicate greater intensity of negative emotions.
|
Baseline and Post Intervention, 8 weeks
|
|
Neuropsychiatric Inventory (NPI-Q)
Time Frame: Baseline and Post Intervention, 8 weeks
|
The NPI-Q is a 12-item questionnaire completed by the caregiver.
Each question asks about a neuropsychiatric symptom over the previous month.
The Caregiver can say "no" and go on to the next question.
If the Caregiver says "yes", the caregive then rates the a) Severity of the symptoms present on a 3 point scale (1=mild to 3 = severe), and b) Distress experienced by the caregiver due to that symptom on a 5 point scale (0 = not distressing at all to 5 very distressing).
|
Baseline and Post Intervention, 8 weeks
|
|
Kingston Caregivers STress Scale
Time Frame: Baseline and Post-Intervention, 8 weeks
|
The KCSS is at 10 item questionnaire completed by a family caregiver.
The questions ask caregivers to report feeling of stress surrounding specific aspects of caregiving.
Caregivers respond using a 5 point scale (1 = no stress to 5 = extreme stress)
|
Baseline and Post-Intervention, 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Karen Barrett, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
February 11, 2026
First Submitted That Met QC Criteria
February 11, 2026
First Posted (Actual)
February 18, 2026
Study Record Updates
Last Update Posted (Actual)
February 23, 2026
Last Update Submitted That Met QC Criteria
February 20, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5K01AG088475-02 (U.S. NIH Grant/Contract)
- 1K01AG088475-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease (AD)
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)RecruitingAlzheimer's Disease (AD) | Healthy AgingUnited States
-
Yuan ShenShanghai Mental Health CenterNot yet recruitingMCI-AD, Early Stage Alzheimer's Disease
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
-
University of Colorado, DenverNational Institute on Aging (NIA)CompletedSuspected Typical Alzheimer's Disease (AD) | Suspected Atypical Alzheimer's Disease (AD)United States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingAlzheimer Dementia | Alzheimer Disease (AD) | MCI-AD, Early Stage Alzheimer's DiseaseChina
-
London Health Sciences Centre Research Institute...Parkwood Hospital, London, OntarioEnrolling by invitation
-
First Affiliated Hospital of Wenzhou Medical UniversityRecruitingEvaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics ApproachsAlzheimer Dementia (AD) | MCI-AD, Early Stage Alzheimer's Disease | Alzheimer s DiseaseChina
-
JYAMS PET Research & Development LimitedRecruitingSubjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) DementiaChina
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruiting
-
Protgen LtdActive, not recruitingAlzheimer's Disease (AD)China
Clinical Trials on Clinical Improvisation
-
Beth Israel Medical CenterCompleted
-
Case Western Reserve UniversityExpanding Horizons InitiativeRecruitingDepression | Anxiety | MoodUnited States
-
Reuth Rehabilitation HospitalUniversity of HaifaRecruitingHemiparesis;Poststroke/CVAIsrael
-
University Health Network, TorontoUniversity of TorontoCompleted
-
St. Joseph's Healthcare HamiltonCompletedDepression | Anxiety | Social Support | Self Concept AlterationCanada
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingCognitive Impairment | Aging | Mild Cognitive Impairment | Cognitive Training | Cognitive Aging | Cognitively Normal Older AdultsUnited States
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedCognitive Impairment | Aging | Mild Cognitive Impairment | Cognitive Training | Cognitive Aging | Cognitively Normal Older AdultsUnited States
-
University of California, San FranciscoActive, not recruiting
-
Chinese University of Hong KongRecruiting
-
Aalborg UniversityUnknown